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INTRODUCTION 
Diabetes mellitus is a multi-metabolic disorder that shares the common phenotype 
of hyperglycemia. 
Globally, Diabetes Mellitus is a major threat to human health. The number of 
people with Diabetes has increased alarmingly since 1985 and the rate of new cases is 
escalating. In 1985, an estimated 30 million people worldwide had diabetes; by 2003, it 
was estimated that approximately 194 million people had diabetes, and this figure is 
expected to rise to almost 350 million by 2025. 
Type 2 Diabetes is a major health problem in India. 
The WHO has highlighted that India currently holds the top spot for most no. of 
people with diabetes and would continue to hold the top position in future also. The 
estimated burden in India would be around 79.4 million by the year 2030. 
Autonomic dysfunction in diabetes is common. Abnormal cardiovascular test 
suggesting cardiovascular autonomic neuropathy is present in 16-40% of diabetic 
population. 
Patients with diabetic cardiac autonomic neuropathy are more prone for sudden 
cardiac death probably due to silent myocardial ischemia or infarction or due to primary 
malignant ventricular arrhythmias. 
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The ECG, which reflects the electrical activity of heart, is liable to show 
abnormalities in diabetics more often than in non-diabetics by virtue of the more 
attendant factors that are more commonly seen in diabetics. In this context the factors that 
modify impulse generation, conduction, nervous control of heart, vascular supply of the 
myocardium, state of myocardium, all required to be considered individually. 
There is a higher prevalence of RBBB and AV block in diabetics that cannot 
accounted by the increased incidence of ischemic heart disease alone. Higher incidence 
of these blocks is seen independent of ischemic heart disease. 
Autonomic dysfunction is often asymptomatic. Hence diagnosing asymptomatic 
cardiac autonomic dysfunction, a precursor of symptomatic cardiac autonomic 
neuropathy will help in a long way in taking sufficient precaution to delay (or) arrest its 
progression by various measures. 
Recent observations noted that corrected QT interval (QTc) in surface ECG seems 
prolonged in diabetics with autonomic neuropathy and postulations are made that it may 
be one of the cause of sudden death or a compounding factor for the predisposition of 
malignant ventricular arrhythmias.  
This highlights the importance of simple noninvasive investigation like ECG in 
diagnosing asymptomatic cardiac autonomic dysfunction.  
3 
 
This study is performed to study the various ECG abnormalities in type 2 Diabetic 
patients to estimate the prevalence of cardiac dysautonomia in type 2 Diabetic patients by 
various ECG markers and to compare with the age and sex matched controls. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 
 
 
AIMS OF THIS STUDY 
1)  To study the various ECG abnormalities in Type 2 Diabetes mellitus patients as 
compared to controls. 
2) To study the prevalence of cardiac dysautonomia in type 2 diabetes mellitus patients 
by various ECG markers. 
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REVIEW OF LITERATURE 
Diabetes mellitus, once regarded as a single entity is now regarded as a 
heterogeneous group of disease characterized by a state of chronic hyperglycemia 
resulting from diverse etiologies, environmental and genetic factors acting together. 
HISTORY 
The first documented evidence of Diabetes mellitus was reported by Egyptian 
papyrus as a polyuric state.  
In 1776, Mathew Dobson estimated the presence of sugar in blood and urine of 
diabetes patients. 
Type 2 Diabetes is the commonest form of diabetes in any country. 
EPIDEMIOLOGY 
The global evidence of Diabetes is estimated to increase from 4% in 1995 to 5.4% 
by the year 2025. India has the dubious distinction of having the highest number of 
diabetics in the world. (1) 
The prevalence in India varies from 1.7 to 9.6 % in various studies. A multi center 
study done by Indian council of medical research showed a prevalence of 1.73 percent in 
Indians above 15 years of age.  According to prevalence of Diabetes in India study 
(PODIs) the prevalence of type 2 diabetes in India is  
Urban-9.6% 
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Rural-4.2% 
Male > female 
CRITERIA FOR THE DIAGNOSIS OF DIABETES MELLITUS (WHO AND 
NATIONAL DIABETES DATA GROUP) (2) 
THE CRITERIA IS BASED ON THE FOLLOWING PREMISES 
1) The spectrum of fasting (FPG) and the response to an oral glucose load (OGTT- 
oral glucose tolerance test) varies among normal individuals. 
2) DM is defined as the level of glycemia at which diabetes-specific complications 
occur rather than on deviations from population based mean.  
CRITERIAS: 
1) Symptoms of diabetes plus random blood glucose concentration ≥ 11.1 
mmol/L (200 mg/dL)a or 
2) Fasting plasma glucose ≥7.0 mmol/L (126 mg/dL)b or 
3) Two-hour plasma glucose ≥ 11.1 mmol/L (200 mg/dL) during an oral glucose 
tolerance testc 
aRandom is defined as without regard to time since the last meal 
bFasting is defined as no caloric intake for at least 8h. 
cThe test should be performed using a glucose load containing the equivalent of 
75 g anhydrous glucose dissolved in water: not recommended for routine 
clinical use. 
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Note: In the absence of unequivocal hyperglycemia and acute metabolic decompensation, 
these criteria should be confirmed by repeat testing on a different day. 
DIABETES AND HEART (3) 
Diabetes involves heart in the following ways 
1. Coronary Artery Disease (CAD) 
2. Small vessel disease 
3. Diabetic Cardiomyopathy 
4. Diabetic autonomic neuropathy 
CORONARY ARTERY DISEASE (CAD) 
Coronary heart disease is about twice frequent in diabetic men and four times 
frequent in diabetic women compared to respective non-diabetics. 
Coronary artery disease is strongly associated with type 2 diabetes mellitus and is 
the leading cause of death regardless of the duration of disease. There is a two to fourfold 
increase in the relative risk ratio of cardiovascular disease in type 2 diabetes patients 
compared to the general population.(4) This increase is particularly disproportionate in 
diabetic women when compared with diabetic men.(4) The protection that premenopausal 
women have against coronary artery disease is not seen if they suffer from diabetes. 
Diabetics are prone for severe, premature and asymptomatic heart disease. 
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SMALL VESSEL DISEASE 
Occlusive disease process affecting the smaller vessel is the hallmark of diabetic 
heart disease. Pathological changes are seen in the endothelium and intima of small 
arteries. The resultant ischemia produces widespread fibrosis in the ventricular 
interstitium with impaired left ventricular (LV) function. 
DIABETIC CARDIOMYOPATHY 
Diabetic cardiomyopathy refers to the derangement in the myocardium in the 
absence of extramural coronary atherosclerosis. Functional disturbances of the 
myocardium with cardiac dilatation are encountered in these subjects. ST and T wave 
changes in ECG are very early in Diabetic cardiomyopathy. 
Diabetic cardiomyopathy is a term used by clinicians to encompass the multi-
factorial etiologies of diabetes-related left ventricular failure characterized by both 
systolic and diastolic function. (5) The Framingham Heart Study showed that men with 
diabetes who have congestive heart failure were twice as common as their non-diabetic 
counterpart, and that females with diabetes had a fivefold increase, in the rate of 
congestive heart failure. The spectrum of heart failure ranges from asymptomatic to overt 
systolic failure. Diabetes complicated by hypertension represents a particularly high-risk 
group for the development of congestive heart failure. (6) Diastolic dysfunction is 
exceedingly common (>50 percent prevalence in some studies) and may be linked to 
diabetes without the presence of concomitant hypertension. 
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The etiology of impaired left ventricular function may involve any of the 
following mechanisms:  
(1) Coronary Atherosclerotic Disease,  
(2) Hypertension 
(3) Left Ventricular Hypertrophy  
(4) Obesity 
(5) Endothelial dysfunction, 
 (6) Coronary microvasculature disease  
(7) Autonomic dysfunction   
(8) Metabolic abnormalities 
DIABETIC AUTONOMIC NEUROPATHY 
Symptoms relating to autonomic involvement in diabetic patients have been 
recognized since the last century (7), but the frequency with which the autonomic system 
is affected was first stressed by Jordan in 1936 and then by Rundles in 1945.  
Autonomic dysfunction in diabetics is common but in sharp contrast symptomatic 
autonomic neuropathy is rare. Diabetic autonomic neuropathy usually accompanies 
peripheral neuropathic disturbances. (3) 
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  Besides atherosclerotic vascular diseases and diabetic heart muscle disease, 
cardiac autonomic neuropathy may also contribute to the excessive cardiovascular 
morbidity and mortality. The main risk factor for autonomic neuropathy was poor 
glycemic control but hyperinsulinemia may have predictive role in the development of 
parasympathetic autonomic neuropathy.  
Interestingly both parasympathetic and sympathetic neuropathies predicted 10 year 
cardiovascular mortality independent of conventional risk factors, hyperglycemia and 
ischemic ECG. (8)  
Diabetic autonomic neuropathy may also associate with an increased risk of stroke 
and lacunar infarcts. In a power spectral analysis of type 2 diabetic patients and control 
subjects, both pro-insulin and C peptide levels were associated with sympatho-vagal 
imbalance of autonomic nervous function (9), and recently it has been shown the 
autonomic nervous dysfunction may be an early finding in subjects with insulin 
resistance. (10) 
PREVALENCE 
The two population based studies, one in Oxford and other in Pittsburgh, recorded 
mainly cardiovascular autonomic function tests. In the Oxford Community Diabetes 
study (11), 202 type 2 diabetics were tested from a total of 402 diabetic patients in the 
community of 29,873. One or more cardiac autonomic tests were abnormal in 15.8% of 
type 2 patients. 
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The Pittsburgh epidemiology of Diabetes Complications study (12) found 
orthostatic hypotension (drop in blood pressure >30 mm Hg) in 3.4% of patients, and the 
most common symptom suggestive of autonomic dysfunction was unawareness of 
hypoglycemia (26%). Other symptoms were uncommon (0-8%). 
Multicenter clinic based studies such as EURODIABIDDM Complications Study 
(13) found orthostatic hypotension in 5.9% and abnormal Heart Rate Variability in 19.3% 
of patients. 
 Ziegler and colleagues (14) (DiaCAN) reported that, in an unselected cohort of type 
2 diabetics, there were borderline cardiac autonomic abnormalities in 12.1% and definite 
abnormalities in 22.1% of patients. It is also recognized that the autonomic function tests 
can be abnormal at the time of diagnosis of diabetes. 
Diabetes is the most common organic cause of male erectile dysfunction, and data 
from Massachusetts Male aging Study show that 64% of men with treated diabetes have 
some degree of erectile problem.(15) Control and duration of diabetes, the presence of 
neuropathy, retinopathy, or nephropathy, and smoking were identified as risk factors for 
impotence. 
In Gastrointestinal studies which are based on clinical symptoms, only early 
satiety, fullness after meals and nausea being significant symptoms compared with the 
controls. Diarrhea was not more frequently encountered in two European studies (16) but 
was more prevalent in type 2 diabetics in a study from Hong Kong.  
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PATHOGENESIS OF DIABETIC AUTONOMIC NEUROPATHY 
The pathologic basis of diabetic autonomic neuropathy is not 
completely understood.  
A number of investigators have identified abnormalities in para-
vertebral sympathetic ganglia, including neurons distended by lipid-rich 
material (17 ,  18), vacuolar degeneration of neurons produced by dilation of 
endoplasmic reticulum, and mononuclear cell infiltration of autonomic 
nerve bundles and ganglia.  
Loss of myelinated nerve fibres has been described in sympathetic 
communicating rami (19), vagus nerves (21), splanchnic nerves (20), and 
nerves to the bladder wall (22). 
Diabetic neuropathies have multi-factorial pathogenic mechanism and clinical 
presentation. Hyperglycemia plays a dominant role in the pathogenesis of diabetic 
neuropathy.  
Both the autonomic and somatic neuropathy may share a common pathogenesis. 
But it is still not clear whether any of the postulated mechanism for somatic nerves also 
apply to autonomic nerves. Following theories are put forth to explain diabetic 
neuropathy. 
 
 
 
13 
 
METABOLIC THEORY (23) 
A) POLYOL THEORY  
The polyol pathway is not dependent on insulin and normally 1% of glucose is 
metabolized through this pathway.  In the presence of hyperglycemia, the excess sugar is 
converted to sorbitol by an enzyme aldose reductase. Increased sorbitol damages 
Schwann cells and has delirious effect on nerve conduction velocity.    
B) MYO-INOSITOL METABOLISM 
Myo-inositol is an important constituent of phospholipids and cell membrane. 
Increased activity of polyol pathway leads to decreased myo-inositol concentration by 
unknown mechanism which inhibits Na+/K+ ATPase activity. 
C) LIPIDS 
Reduction in membrane cholesterol, cerebroside, sphingomyelin, phosphotidyl 
serine, phosphotidylinositol, is encountered in diabetic neuropathy. The synthesis of 
myelin which is rich in these lipids is also likely to be reduced contributing to 
neuropathy. 
D) TAURINE 
Osmo-regulation, in order to maintain the intracellular milieu, may 
also result in endo-neurial metabolic changes in diabetic neuropathy. The 
increase in intracellular osmolality due to shunting of glucose into the 
polyol pathway and the consequent accumulation of sorbitol may lead to 
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compensatory depletion of the endo-neurial osmolytes taurine and myo-
inositol to maintain osmotic balance.  
E) OXIDATIVE STRESS 
Oxidative stress also is implicated in the etiology of diabetic 
neuropathy. There is evidence that activity of oxygen-free radicals is 
enhanced in diabetes. Indices of increased oxidative stress such as 
malondialdehyde, conjugated dienes, and lipid hydroperoxides are increased 
in experimental diabetic neuropathy. 
F) PROTEIN KINASE C ACTIVATION 
Protein kinase C elevations compromise nerve regeneration in 
experimental models of diabetic peripheral neuropathy. In experimental 
models of diabetes, treatment with nonspecific and β-specific protein 
kinase C inhibitors normalized the observed neurophysiologic 
abnormalities. 
G) POLY (ADP-RIBOSE) POLYMERASE 
There is increasing evidence that poly (ADP-ribose) polymerase 
(PARP) plays a critical role in mediating several pathways of 
hyperglycemia-induced damage.  
H) NEUROTROPHIC FACTORS 
The neurotrophins are proteins that promote the growth, maintenance, 
survival, and differentiation of specific populations of neurons. There is 
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evidence that failure of neurotrophic support is in part responsible for the 
pathogenesis of diabetic polyneuropathy. 
VASCULAR THEORY 
Hyperglycemia-related metabolic alterations produce interposed 
changes in tissues and the microvasculature that are then responsible for 
ischemic pathologic changes in nerve fibres.   
Lundback proposed a unifying hypothesis of wide spread small vessel angiopathy 
underlying most diabetic complications of the eye, kidney and nerves. A concept there 
after arises of a common micro vascular etiology for diabetic neuropathy, retinopathy and 
nephropathy exemplified by the term “triopathy”. 
Support for this hypothesis was provided by histopathological studies of 
vasovasorum of peripheral nerves from patients with neuropathy showing thickening, 
hyalinisation and accumulation of PAS positive material in the vessel wall and narrowing 
or occlusion of the lumen.  
Dyck and colleagues(24)  observed thickening of capillary walls and 
documented capillary closure and platelet thrombi occlusions in the small 
arteries and arterioles that supply peripheral nerves that was more 
pronounced in patients with diabetic neuropathy than in age-matched 
controls. 
Timperty et al. recently described intraluminal changes of the vasonervorum with 
intravascular coagulation in several nerve biopsies. The most consistently reported 
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ultra structural micro vascular abnormalities in diabetic neuropathy are 
basement-membrane thickening and endothelial-cell hyperplasia.  
Several studies have established a correlation between ultra structural 
micro vascular disease in peripheral nerve and severity of diabetic 
neuropathy. (24)  
It is difficult to pinpoint a particular pathologic mechanism in diabetic neuropathy 
except in certain mononeuropathies. Metabolic and vascular factors, together with 
glycosylation of protein, hyper-aggregation of platelets and altered haemo-rheology may 
contribute to the development of neuropathy. 
PATHOLOGY 
Duchene had studied the sympathetic ganglia in five diabetics with autonomic 
neuropathy. 
He described vacuolated and granular cell necrosis, loss of myelinated nerve fibres 
in vagus and splanchnic nerves and loss of neurons in the intermediolateral columns of 
spinal cord. 
  Feerman et al (1977) showed changes in the autonomic nerves and ganglia such as 
beaded thickening, hyperargenophilia in nerves, spindle shaped nerve fibres, 
fragmentation of fibres and decrease in number of fibres.  
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Diabetes results in a predominantly axonal neuropathy with an increasing gradient 
of nerve fibre loss from center to periphery (a dying back neuropathy). There is in 
addition a disturbance in axonal transport in experimental diabetes produced by 
streptozotocin. There is a decrease in fast component of axonal transport, segmental 
demyelination independent of axonal damage is also found.  
It is also thought to be the result of damage to Schwann cells in the diabetic 
process. Myelin degeneration and regeneration may give rise to onion bulb formation. 
There is also a depletion of small myelinated and unmyelinated fibres. Microvasculature 
of endo-neurial capillaries show thickening and widening of the peri-neural basement 
membrane. Small vessel occlusion may also be present. 
   Total cardiac denervation is possible but usually the parasympathetic fibres are 
involved earlier than the sympathetic fibres. However both may be differentially 
involved. Evidence would now suggest that there is a simultaneous impairment of both 
the sympathetic and parasympathetic pathways rather than a progressive model of 
parasympathetic dysfunction preceding damage of the sympathetic neurons. (25) 
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CLINICAL FEATURES OF AUTONOMIC NEUROPATHY (26) 
1. CARDIOVASCULAR  
¾ Postural hypotension 
¾ Painless Myocardial Infarction/ischemia 
¾ Resting tachycardia 
¾ Loss of heart rate variation 
¾ High peripheral blood flow 
¾ Rigidity/calcification of arteries 
¾ Neuropathic  edema 
¾ Diabetic cardiomyopathy 
2. GASTROINTESTINAL 
¾ Dyspepsia, Dysphagia and esophageal ulcerations- Impaired esophageal motility 
¾ Gastroparesis-Gastric atony 
¾ Diarrhea- small intestinal dysfunction 
¾ High incidence of cholesterol stones (Gall bladder motility impaired) 
¾ Constipation- Colonic atony 
3. UROGENITAL 
¾ Bladder dysfunction 
¾ Impaired bladder sensation 
¾ Bladder over distension 
¾ Impotence 
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¾ Retrograde ejaculation 
¾ Loss of testicular sensation 
¾ Female sexual dysfunction 
4. SUDOMOTOR AND THERMO REGULATORY DISORDERS 
¾ Diabetic anhydrosis 
¾ Gustatory sweating 
¾ Nocturnal sweating 
¾ Abnormal vasomotor responses 
5. PUPILLARY ABNORMALITIES 
¾ Reducing resting diameter 
¾ Delayed (or) absent response to light 
¾ Diminished hippus 
¾ Iritis 
6. VASOMOTOR 
¾ Loss of skin vasomotor responses 
¾ Peripheral vascular changes 
¾ Dependent edema 
7. RESPIRATORY 
¾ Respiratory arrest 
¾ ?Sleep apnea 
¾ Cough reflex reduced 
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8. HYPOGLYCEMIA UNAWARENESS 
¾  Decreased catecholamine release with loss of warning symptoms of 
hypoglycemia 
¾ Decreased pancreatic glucagon and pancreatic polypeptide release 
9. NEUROENDOCRINE 
¾ Catecholamines reduced 
¾ Glucagon reduced 
¾ Pancreatic polypeptide reduced 
10. OTHER CONSEQUENCES OF DIABETIC AUTONOMIC 
NEUROPATHY 
¾ Contribution to pathogenesis of Diabetic foot 
¾ Worsening of diabetic retinopathy 
PROGNOSIS 
  Autonomic function declines with age, but in diabetes it deteriorates, on average, 
faster than in normal subjects. Thus variation in heart rate which normally decreases at 
about 1 beat/min every 3 years declines about three times faster in diabetic patients, 
although there is substantial variation. (35)   
Most patients who develop abnormal autonomic function do not become symptomatic. 
Mortality of asymptomatic patients with autonomic dysfunction may be increased but the 
prognosis is generally good, and 90% of our patients (all under 50 years old at the 
beginning of the study) were alive 10 years later. By contrast, the outcome for those with 
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symptomatic autonomic neuropathy is not as good, although even in this group, 73% 
were still alive after a decade.  
Ewing et al (36) reported a poorer prognosis, although patient selection was 
different: the patients were older and some had renal damage. Those with orthostatic 
hypotension seem to have the highest mortality, perhaps because of the premature 
development of left ventricular hypertrophy.  
Most deaths in these patients are from renal failure or myocardial infarction. There 
are a few sudden unexplained deaths among patients with autonomic neuropathy, which 
might be due to respiratory arrest rather than cardiac arrest or arrhythmia.  
Established symptoms of autonomic neuropathy, including diarrhea, vomiting 
from Gastroparesis and postural hypotension run a very protracted although intermittent 
course and rarely become disabling, even over a 10 to 15 year period. (35)  
Postural hypotension fluctuates substantially with a corresponding variation in the 
intensity of symptoms. Gustatory sweating also tends to persist without remission, 
although many patients describe disappearance of this symptom after renal 
transplantation.  
The general absence of progression to debilitating disease remains unexplained 
and contrasts with devastating and, indeed, often fatal progression of the primary 
autonomic failure.  
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Malins made many of these observations some years ago and wrote that “The 
prognosis for autonomic manifestations is poor although the disability is often 
surprisingly slight.” (37)  
AUTONOMIC NERVOUS SYSTEM OF THE HEART 
 Autonomic nervous system innervates every visceral organ of the body. It controls 
sympatho-vagal actions via neurotransmitters like acetyl-choline and nor-epinephrine to 
maintain internal homeostasis. These actions are largely automated (or) involuntary, 
possibly because of their complex and important nature.  
Their importance was well recognized by Claude Bernaud who said “the nature 
thought it provident to remove these important phenomenon from the caprice of ignorant 
will”. 
The heart possesses an inherent ability to impulse generation and conduction, but 
autonomic nervous system plays an important role in myocardial excitability and 
contractility. 
 Parasympathetic fibres from the vagus and sympathetic fibres from upper 4 to 5 
thoracic ganglion innervate heart and mediate autonomic control. These innervations 
inform the stretch receptors in systemic and pulmonary vessels continuously and thus 
monitor intravascular pressure.  
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The highlight of autonomic control is that it acts rapidly and constantly to the 
changes threatening internal environment. Important function under autonomic regulation 
include maintenance of blood column and tissue perfusion, blood pressure, extracellular 
fluid and its composition, smooth muscle and glandular functions.  
AUTONOMIC NEURAL CONTROL OF THE HEART 
Autonomic regulation of the heart and vasculature is primarily controlled by 
special regions within the medulla oblongata of the brainstem that contain the cell bodies 
of sympathetic and parasympathetic (vagal) efferent nerves. The hypothalamus plays an 
integrative role by modulating medullary neuronal activity (e.g., during exercise). 
  Sensory information from peripheral baroreceptors (e.g., carotid sinus 
baroreceptors) synapses within the medulla at the nucleus tractus solitarius, which 
modulates the activity of the sympathetic and vagal neurons within the medulla. 
PARASYMPATHETIC INNERVATION 
Preganglionic parasympathetic efferent nerves exit the medulla as the tenth cranial 
nerve and travel to the heart within the left and right vagus nerves. Preganglionic fibres 
synapse within ganglia located within the heart; short postganglionic fibres innervate the 
myocardial tissue.  
Parasympathetic activation decreases heart rate, inotropy, and dromotropy, and it 
produces vasodilation in specific organs through the release of acetylcholine, which binds 
to postjunctional muscarinic (M2) receptors. 
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SYMPATHETIC INNERVATION 
  Preganglionic sympathetic efferent nerves exit from the spinal cord and synapse 
within paravertebral or prevertebral ganglia before sending out postganglionic fibres to 
target tissues in the heart and blood vessels.  
Sympathetic activation increases heart rate, inotropy, and dromotropy through the 
release of norepinephrine, which binds primarily to postjunctional cardiac β1-
adrenoceptors.  
Norepinephrine released by sympathetic nerves constricts blood vessels binding to 
postjunctional α-1 and α2- adrenoceptors. The release of norepinephrine from 
sympathetic nerve terminals is modulated by prejunctional α2-adrenoceptors, β2-
adrenoceptors and muscarinic (M2) receptors. 
BARORECEPTOR FEEDBACK REGULATION OF BP 
Baroreceptors are mechanoreceptors that respond to stretch induced by an increase 
in pressure or volume.  
Arterial baroreceptor activity (e.g., carotid sinus and aortic arch receptors) 
tonically inhibits sympathetic outflow to the heart and blood vessels, and it tonically 
stimulates vagal outflow to the heart.  
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Decreased arterial pressure, therefore, decreases the firing of arterial 
baroreceptors, which leads to reflex activation of sympathetic influences acting on the 
heart and blood vessels and withdrawal of the vagal activity to the heart. 
EFFECT OF SYMPATHETIC AND PARASYMPATHETIC STIMULATION OF 
CARDIAC AND VASCULAR FUNCTION 
HEART SYMPATHETIC PARASYMPATHETIC 
Chronotropy(rate) +++ _ _ _ 
Dromotropy 
(conduction velocity) 
+++ _ _ _ 
Inotropy(contractility) ++ _1 
1 more pronounced in the atria than in the ventricles 
CHEMORECEPTORS FEEDBACK REGULATION 
Peripheral chemoreceptors (e.g., carotid bodies) and central chemoreceptors (e.g., 
medullary chemoreceptors) respond to decreased pO2 and pH or increased pCO2 of the 
blood.  
Their primary function is to regulate respiratory activity, although chemoreceptor 
activation generally leads to activation of the sympathetic nervous system to the 
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vasculature, which increases arterial pressure. Heart rate responses depend upon changes 
in respiratory activity. 
 
CARDIAC DYSAUTONOMIA (27) 
Cardiac dysautonomia refers to autonomic dysfunction of the heart. It appears to 
be the most frequent complication of diabetes. It includes 
1. Autonomic neuropathy 
 Refers to combined clinical and objective evidence of autonomic involvement. 
2. Autonomic dysfunction  
 Refers to abnormal cardiovascular tests in absence of clinical symptoms. 
Autonomic dysfunction in diabetes is common (20-50%) but symptomatic 
autonomic neuropathy is less common (12% in IDDM and 1% in NIDDM). 
NATURAL HISTORY 
A 10 year study of type 2 diabetics in Finland (28) found that cardiac autonomic 
function assessed with an E:I ratio [(sum of six longest R-R intervals occurring during 6 
expirations) / (sum of the shortest R-R intervals occurring during 6 inspirations)] rose 
from 5%(controls 2%) at the beginning to 65%(controls 28%) at the end of the study. 
Changes in systolic blood pressure on standing increase from 7 to 24 %( controls 6% to 
9%).  
27 
 
The development of autonomic neuropathy correlated with poor glycemic control. 
This was also noted by Ziegler and co-workers (29) in a clinic based study in Germany.  
Further evidence supporting a gradual progression of autonomic neuropathy with 
time comes from clinic based studies showing a deterioration in autonomic function test 
scores in 57% of type 2 diabetics over 5 years (30) and a separate study of older patients 
showed that autonomic function test abnormalities increased from 41% at baseline to 
64%(31). 
EFFECTS OF SYMPATHOVAGAL IMBALANCE (32) 
1. Impairs angina recognition 
     Silent ischemia and infarction 
2. Alters threshold for ischemia 
     Increased resting heart rate and blunted chronotropic response to exercise. 
     Impaired coronary vasomotor regulation. 
3. Abnormality in diastolic and systolic function 
     Contributes to cardiomyopathy 
4. Increased risk of ventricular arrhythmia 
     Contributes to sudden cardiac death 
5. Altered circadian pattern of triggering of acute cardiac events 
     Leads to loss of nocturnal protection against acute Myocardial infarction 
6. Altered circadian blood pressure regulation leads to 
     Increased cardiac mass 
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     Risk factor of microalbuminuria and diabetic nephropathy 
    Adversely affects the natural history of congestive cardiac failure 
    Causes hemodynamic instability in peri-operative period 
CLINICAL PRESENTATION 
  Autonomic damage may be asymptomatic and thus be detected incidentally, even 
if symptomatic, the condition often goes unnoticed for a considerable time partly of the 
vagueness of many of early symptoms. The proportion of asymptomatic subjects 
increases with increasing duration of diabetes. 
The features of cardiac autonomic neuropathy include 
1) Exercise intolerance 
2) Postural hypotension 
3) Resting tachycardia 
4) Fixed heart rate 
5) Painless (or) silent myocardial infarction 
Although insidious in onset, autonomic neuropathy may be associated with 
substantial morbidity. In fact, sudden death and cardio respiratory arrest in diabetes have 
been attributed to cardiac autonomic dysfunction. 
Mortality associated with autonomic neuropathy after clinical diagnosis has been 
reported to be as high as 50% in 3 years and its presence has been suggested to serve as a 
poor prognostic indicator. In a five year follow up study, the mortality rate of diabetes 
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with autonomic neuropathy was 56% as against 21% in those without autonomic 
neuropathy (33). 
Patients with autonomic neuropathy are also at a higher risk of sudden death. 
1) Exercise intolerance 
Diabetic with autonomic neuropathy achieve a lower heart rate, blood pressure and 
cardiac output on exercise compared to diabetics without this complication. It results in 
poor exercise tolerance. 
2) Postural hypotension. 
 The most serious clinical consequence of vascular denervation is orthostatic 
hypotension. It is due to diminished peripheral vasoconstriction and some failure of 
splanchnic blood flow reduction on standing, but these defects are not as marked as 
would be expected even in severe cases. Noradrenaline concentrations are normally 
reduced in these patients, whereas renin responses may or may not be abnormal.  
 Measured orthostatic hypotension, defined as a decrease of systolic blood pressure 
on standing of more than 30 mm Hg, is not uncommon in diabetic neuropathy although 
symptoms are rare. Patients may then complain at the least of mild giddiness and at most 
may be disabled by the condition, unable to stand for more than a few minutes at a time, 
although this state is very rare. 
  Symptoms range from mild giddiness or muzzy headedness on standing up, 
progressing to a grey mistiness of vision followed by a curious pain in the back of the 
neck and shoulders in a "coat hanger" distribution (40) and later unconsciousness. 
Distortion of vision can occur.  
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 Symptoms are often worse on rising from bed in the morning, but they vary 
substantially both through the day and from week to week, ranging from negligible to 
severe. They do not show very close correlation with actual fall of blood pressure 
although when the systolic pressure is less than 70 mm Hg few patients can remain 
upright.  
 Orthostatic hypotension is exacerbated by insulin administration, (38, 39) and just 
occasionally episodes of loss of consciousness from insulin induced orthostatic 
hypotension are confused with those from hypoglycemia. Orthostatic hypotension can 
persist over many years and apart from the rare patients who develop disabling disease it 
often fails to progress even during 10-15 years. It never remits completely.  
In 1945, Rundles first linked postural hypotension with autonomic neuropathy in 
diabetics (34). The blood pressure fall may be worsened by a variety of drugs including 
hypotensive agents, diuretics, tricyclic antidepressants, phenothiazines, nitrates, 
vasodilators etc. Insulin may aggravate postural hypotension possibly through a direct 
vasodilator action on peripheral blood vessels. Conversely fluid retention in congestive 
cardiac failure (or) nephritic syndrome may mask postural hypotension. 
3)  Resting heart rate 
There are several reports of resting heart rate in excess of 95/minute in diabetics 
with autonomic damage and some times more rapid rates up to 130/minute occur. An 
overall increase in mean heart rate of about 10/minute has been reported.  
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Diabetics with cardiac parasympathetic damage had the fastest rates (may 
represent the initial stages of autonomic dysfunction) and those with additional 
sympathetic damage have slightly slower heart rate. 
4) Fixed heart rate 
Heart rate show less diurnal variation with increasing autonomic damage. The loss 
of the normal cardiac slowing at night occurs as a result of vagal damage. With severe 
damage there is a loss of minute and second to second variation in heart rate, resulting in 
relatively fixed rate. 
5) Painless (or) silent Myocardial Infarction 
Autonomic neuropathy may reduce the perception of cardiac ischemic pain. 
Diabetic patients admitted to the hospital with Myocardial infarction have been reported 
to have less intense pain than non diabetic patients. 
Margolis (41) et al reviewed the ECG of all patients in Framingham heart study and 
found that 23% of myocardial infarction was silent. 
 The significance of reduction in ischemic pain is that, silent myocardial damage 
may occur more likely and this may be the basis for the increased prevalence of 
ischemic cardiomyopathy in diabetes. It may be responsible for diabetic patients 
suffering from infarction reaching late to hospital. 
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ECG CHANGES IN DIABETICS 
The QT interval in the ECG reflects the total duration of ventricular myocardial 
depolarization and repolarization. 
A role of autonomic neuropathy in duration of QT interval in diabetic patient has 
been proposed because the diabetic patient with autonomic dysfunction show longer 
QTc compared with those without autonomic dysfunction (43). 
The men with impaired heart rate variability (an index of autonomic dysfunction) 
showed significantly higher QTc compared with men without these complications 
suggesting a role for autonomic dysfunction in QTc prolongation in men (43). 
Diabetics have a prolonged PR interval and more leftward frontal QRS axis than 
their non diabetic counterparts (44). 
There is no significant difference in QRS duration between diabetics and non 
diabetics. 
There is an increase incidence of intraventricular conduction blocks in diabetic 
patients than that of normal (45). 
PATHOLOGY OF CONDUCTION 
The arrhythmias which occur in Diabetics are related to the complication of the 
disease (i.e.) arteriosclerotic coronary heart disease, aging, sclerosing the left side of 
cardiac skeleton and monkeburg’s sclerosis of the arteries.  
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Sinuatrial block or atrioventricular block can occur acutely in Myocardial 
infarction and in chronic states due to atherosclerosis of large arteries (or) fatty 
infiltration of the node itself isolating from the rest of the myocardium. (10) 
   Various types of bundle branch blocks such as RBBB, LBBB, LAHB, LPHB, 
alternating bundle branch block may occur in diabetes. In the acute type it is usually 
caused by infarction and in the chronic type it is due to arteriosclerosis of the left side of 
the skeleton, a process accelerated in diabetics. (10) 
ASSESSMENT OF CARDIOVASCULAR AUTONOMIC DYSFUNCTION 
Objective evidence of autonomic nerve damage is based on cardiovascular 
reflexes as these are reliable and quantitative non invasive methods to assess autonomic 
nervous system function.  
Implicit in the use of cardiovascular reflex test is the assumption that it reflects 
damage throughout the autonomic nervous system. This is largely true except for the very 
early manifestation such as sweating loss on the feet and impotence which may antedate 
abnormal cardiovascular tests. 
TESTS FOR PARASYMPATHETIC FUNCTION 
1) Heart rate response to deep breathing (HRBD) 
2) Heart rate response to standing 
3) Heart rate response to valsalva maneuver 
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TESTS FOR SYMPATHETIC FUNCTION 
1) BP response to standing 
2) BP response to sustained handgrip  
HEART RATE RESPONSE TO DEEP BREATHING (HRBD) 
The patient sits quietly and breaths deeply at 6 breaths a minute (5 seconds in and 
5 seconds out) for one minute. An ECG is recorded throughout the period of deep 
breathing with a marker used to indicate the onset of each inspiration and expiration.  
The maximum and minimum R-R intervals during each breathing cycle are 
measured and converted into beats/minute. The result is then expressed as the mean of 
the difference between maximum and minimum heart rates for the 6 measured cycles in 
beats/minute. 
(Normal response ≥ 15 beats/minute, Borderline 11-14 beats/minute, Abnormal 
response ≤ 10 beats/minute). 
The normal acceleration and deceleration of heart rate during respiration (sinus 
arrhythmia) is reduced early in course due to cardiac vagal involvement. This 
phenomenon provides the basis for the simplest and most sensitive test for the presence 
of cardiac autonomic dysfunction.  
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HEART RATE RESPONSE TO STANDING 
The test is performed with the patient lying quietly on a couch while heart rate is 
recorded continuously on ECG machine. The patient is asked to stand up unaided and the 
point at starting to stand is marked on ECG.  
The shortest R-R interval at or around the 15th beat and largest R-R interval at or 
around the 30th beat after starting to stand are measured with a ruler. The characteristic 
heart rate response was expressed by 30:15 ratio, which is normal if > 1.04, borderline 
between 1.01and 1.03 and abnormal if < 1.00. 
BLOOD PRESSURE RESPONSE TO STANDING UP 
The test is performed by measuring the patient’s BP while he is lying down quietly 
and again when he stands up. The postural fall in BP is taken as the difference between 
systolic BP lying and the systolic BP standing (Normal response ≤ 10 mm Hg, Borderline 
11-29 mm Hg, Abnormal response ≥ 30 mm Hg).  
HEART RATE RESPONSE TO VALSALVA MANEUVER 
The test is performed by the patient blowing into a mouth piece connected to a 
sphygmomanometer and holding it at a pressure of 40 mm Hg for 15 seconds while a 
continuous ECG is recorded.  
The maneuver is performed 3 times with interval of one minute in between. The 
result is expressed as the Valsalva ratio which is the ratio of the longest R-R interval after 
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the maneuver to the shortest R-R interval during the maneuver. The mean of three 
Valsalva ratio is taken as the final value.  
(Normal Valsalva ratio ≥ 1.21, Borderline between 1.11 and 1.20, Abnormal ≤ 
1.10).   
BLOOD PRESSURE RESPONSE TO SUSTAINED HAND GRIP 
   Blood pressure is measured with 30% of maximum voluntary contraction using a 
hand grip dynometer for 5 minutes. The difference between the diastolic blood pressure 
just before starting and just before releasing the hand grip is taken as a measure of 
response. (Normal ≥ 16mmHg., Borderline 11-15 mm Hg., Abnormal ≤10 mm Hg.) 
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MATERIALS AND METHODS 
MATERIALS 
STUDY POPULATION 
1) Study group- 50 patients with type 2 diabetes mellitus 
2) Control group- 50 age and sex matched controls 
PLACE OF STUDY 
 Out patients department, 
Department of medicine, 
Department of diabetology, 
Stanley medical college, 
Chennai-1. 
PERIOD OF STUDY 
Feb 2008 to September 2009 
METHODS 
  All the study population and controls were subjected for thorough physical 
examination.  Blood samples were drawn and subjected to estimation of causal blood 
glucose and renal function tests. 
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INCLUSION CRITERIA 
 Type 2 diabetes patients except the ones with the following exclusion criteria 
 EXCLUSION CRITERIA 
1) Age > 60 years 
2) Documented CAD/ischemic heart disease 
3) Documented valvular heart disease/congenital heart disease. 
4) Hypertension 
5) Uremia 
6) Drugs-any drug which alters the sinus node impulse generation and AV conduction. 
7) Features of hypo and hyperthyroidism. 
8) Fever and features suggestive of infections 
9) Chronic obstructive pulmonary disease and other chronic lung disorders. 
10) Parkinsonism and other movement disorders  
11) Dyselectrolytemia 
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Autonomic dysfunction was assessed by the following maneuvers 
PARASYMPATHETIC FUNCTION 
1) Tachycardia in resting ECG 
2) Heart rate  response to deep breathing (HRBD) 
SYMPATHETIC FUNCTION 
1) Blood pressure response to standing 
2) QTc prolongation 
 Various parameters that will be obtained are to be compared between study and 
control group using either unpaired‘t’ test.  
ELECTROCARDIOGRAM 
 Resting ECG was taken both in the study and control group using a three leaded 
Schillar Cardiovit AT machine. 
 ECG during deep breathing was recorded only in study group (diabetics) using 
single leaded BPL ECG machine. The lead preferred is Lead II. 
The subjects were made to lie down quietly. Then they were asked to The patient 
takes deep breath and evenly at a rate of six breaths per minute (i.e.) five seconds for 
inspiration and five seconds for expiration. A continuous ECG was recorded for one 
minute.  
. The maximum and minimum R-R intervals during each breathing cycle were 
measured and converted into beats/minute. The result was then expressed as the mean of 
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the difference between maximum and minimum heart rates for the 6 measured cycles in 
beats/minute. <10 beats variation is taken as abnormal. 
QTc INTERVAL 
R-R and QTc intervals were measured with a meter on the resting ECG tracing. 
The lead considered here is lead V2. 
The QT interval was measured from the beginning of QRS Complex to the down 
slope of the T wave (crossing the iso-electric line) 
When a U wave was present, the QT interval was measured to the nadir of T wave 
and U wave. 
The corrected QT interval for the previous cardiac cycle length (QTc) was 
calculated using Bazett’s formula 
                                        QTc=    QT / ) 
A QTc > 460 msec is considered abnormally prolonged. 
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OBSERVATIONS AND DATA ANALYSIS 
1) AGE AND SEX DISTRIBUTION 
 
More than half of the study population belongs to the age group of 41-50 years (56%). 
2) DURATION OF DIABETES 
STUDY GROUP (DIABETICS) 
DURATION NO. % 
0-5 YRS 28 56% 
6-10YRS 14 28% 
11-15YRS 6 12% 
16-20YRS 1 2% 
>20YRS 1 2% 
 
More than 50% of the study population has duration of diabetes less than 5 years. 
CONTROL GROUP 
 
STUDY GROUP 
 YEAR 
MALES FEMALES TOTAL % MALES FEMALES TOTAL % 
21-30 1 0 1 2% 1 0 1 2% 
31-40 8 5 13 26% 8 5 13 26% 
41-50 13 15 28 56% 13 15 28 56% 
51-60 3 5 8 16% 3 5 8 16% 
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ECG ABNORMALITIES 
3) RESTING HEART RATE 
RESTING HEART RATE 
GROUPS 
Range(bpm) Mean(bpm) 
Study(diabetics) 56-110 84.2±12.86 
Control 56-100 75.2±10.65 
 
*p Value= 0.0001 *Unpaired ‘t’ test 
The mean resting heart rate of study (diabetics) group (84.2±12.86bpm) is significantly 
higher (p<0.05) than that of control group (75.2±10.65). 
4) R-R INTERVAL 
R-R INTERVAL 
GROUPS 
Range(msec) Mean(msec) 
Study(diabetics) 550-1070 725.4±121.49 
Control 600-1070 815.4±114.41 
 
*p value-0.0002 *Unpaired ‘t’ test 
The R-R interval of study group (725.4±121.49msec) is significantly lower (p<0.05) 
than that of controls (815.4±114.41msec) correlating with the increased heart rate 
signifying parasympathetic damage. 
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5) PR INTERVAL 
P-R INTERVAL 
GROUPS 
Range(msec) Mean(msec) 
Study(diabetics) 120-240 162.4±11.67 
Control 120-180 138.2±16.99 
 
*p value-0.0001 *Unpaired ‘t’ test  
 The PR interval of study group (162.4±11.67msec) is significantly (p<0.05) higher than 
that of control group (138.2±16.99msec). 
6) QRS DURATION 
QRS DURATION 
GROUPS 
Range(msec) Mean(msec) 
Study(diabetics) 60-100 68.4±11.67 
Control 60-80 65±8.69 
 
*p value- 0.1016 * Unpaired ‘t’ test. 
The QRS duration in prolonged in study group (68.4±11.67msec) as compared to that of 
controls (65±8.69msec). But it is not statistically significant. (p>0.05). 
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7) QRS AXIS  
QRS AXIS 
GROUPS 
Range(degrees) Mean(degrees) 
Study(diabetics) -45   -   +90 26.4±30.54 
Control -15   -   +100 67.6±27.82 
 
*p value-0.0001 *Unpaired ‘t’ test 
The QRS axis of study group is more towards left (26.4±30.54 degrees) as 
compared to that of controls (67.6±27.82 degrees) which is statistically 
significant(p<0.05). 
 
8) QTc INTERVAL 
QTc INTERVAL 
GROUPS 
Range(msec) Mean(msec) 
Study(diabetics) 345-595 405.16±40.38 
Control 302-415 365.38±25.3 
        
 *p value-0.0001 * Unpaired ‘t’ test 
The QTc interval in study group (405.16±40.38 msec) is significantly prolonged (p<0.05) 
than the controls (365.38±25.3 msec). 
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9) ECG CHANGES OF ISCHEMIA AND INFARCTION 
EVIDENCE OF ISCHEMIA EVIDENCE OF INFARCTION 
GROUPS 
NO. % NO. % 
Study(diabetics) 13 26% 5 10% 
Control 6 12% 3 6% 
 
The ECG changes of ischemia and infarction is significantly higher in the study group 
(26%&10% respectively) when compared to the control group (12%&6%). 
 
10) CORRELATION BETWEEN ECG AND SYMPTOMS OF IHD 
SYMPTOMATIC 
 
ASYMPTOMATIC 
 GROUPS ECG CHANGES 
NO. % NO. % 
Study(diabetics) 18 13 72.22% 5 27.78% 
Control 9 8 88.89% 1 11.11% 
 
Prevalence of asymptomatic heart disease in the study group (27.78%) is higher when 
compared to the control group (11.11%). 
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11) INCIDENCE OF INTRAVENTRICULAR CONDUCTION BLOCKS 
GROUPS NUMBER % 
Study Group 4 8% 
Control Group 1 2% 
 
The prevalence of intraventricular conduction defect is higher in the study group when 
compared to that of controls. 
 
12) HEART RATE RESPONSE TO DEEP BREATHING (HRBD)                            
STUDY GROUP (DIABETICS) 
HRBD NUMBER % 
NORMAL HRBD 
(>15 beats per min) 
36 72% 
ABNORMAL HRBD (<10 
beats per min) 
14 28% 
 
28% of study group have abnormal HRBD suggesting early parasympathetic dysfunction. 
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13) SIGNIFICANT POSTURAL DROP OF SBP (>30 mm Hg) 
Postural fall of SBP 
(>30 mm Hg) 
Number % 
Study (Diabetics) 3 6% 
Control 0 0% 
 
6% of the study group show significant postural drop of SBP (>30 mm Hg) on 
standing which probably indicates sympathetic nervous system dysfunction. 
 
14) QTc INTERVAL CORRELATION WITH SIGNIFICANT POSTURAL 
DROP IN SBP (SBP>30 mmHg) 
                                      STUDY GROUP (DIABETICS) 
PARAMETERS NUMBER % 
 QTc >460msec 4 8% 
Fall in SBP > 30 mm Hg 3 6% 
  
There is a positive correlation between QTc prolongation and significant postural fall in 
SBP. All the three patients had significant QTc prolongation. 
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RESULTS 
1. The mean resting heart rate of study (diabetics) group (84.2±12.86bpm) is 
significantly higher (p<0.05) than that of control group (75.2±10.65). 
2. The R-R interval of study group (725.4±121.49msec) is significantly lower 
(p<0.05) than that of controls (815.4±114.41msec). 
3. The PR interval of study group (162.4±11.67msec) is significantly (p<0.05) 
higher than that of control group (138.2±16.99msec). 
4. The QRS duration is prolonged in study group (68.4±11.67msec) as compared 
to that of controls (65±8.69msec). But it is not statistically significant. 
(p>0.05). 
5. The QRS axis of study group is more towards left (26.4±30.54 degrees) as 
compared to that of controls (67.6±27.82 degrees) which is statistically 
significant(p<0.05). 
6. The QTc interval in study group (405.16±40.38 msec) is significantly 
prolonged (p<0.05) than the controls (365.38±25.3 msec). 
7. The ECG changes of ischemia and infarction is significantly higher in the 
study group (26%&10% respectively) when compared to the control group 
(12%&6%). 
8. Prevalence of asymptomatic heart disease in the study group (27.78%) is 
higher when compared to the control group (11.11%). 
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9. The prevalence of intraventricular conduction blocks in diabetics (8%) is 
higher than that of controls (2%). 
10. 28% of study group have abnormal HRBD suggesting early parasympathetic 
dysfunction. 
11. 6% of the study group show significant postural drop of SBP (>30 mm Hg) on 
standing which probably indicates sympathetic nervous system dysfunction. 
12. There is a positive correlation between QTc prolongation and significant 
postural fall in SBP (>30 mm Hg). All the three patients had significant QTc 
prolongation. 
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DISCUSSION 
This study compares the ECG changes of 50 type 2 diabetes patients with equal 
number of age and sex matched controls to find out any differences in abnormalities, if 
any, in diabetic patients. By using conventional ECG parameters, this study also 
delineates the prevalence of autonomic dysfunction in the diabetic population. 
The mean resting heart rate in diabetics was found to be 84.88±12.86msec as 
compared to that of non-diabetic controls which was 74.28±10.65msec. Thus diabetic 
patients had a mean resting heart rate that was significantly higher than of non-diabetics. 
(p value<0.05). 
Kahn J.K. et al found that patients with cardiac dysautonomia have higher resting 
heart rates and lower maximal heart rates during exercise than diabetic patients with-out 
autonomic neuropathy (57).  
The measurement of PR interval that reflects the AV conduction showed that 
mean PR interval was (162.4±31.72) in diabetics as against (138.2±16.986) in non-
diabetic population, which was statistically significant. 
According to Uuisipta and M.Mushronan, the PR interval was prolonged in 
diabetics than normal. 
The QRS duration in diabetics was not significantly prolonged than that in non-
diabetics in this study. 
54 
 
The QRS axis in diabetics was significantly shifted leftwards (26.4±30.54 degrees) 
as compared to that of non-diabetics (67.6±27.82 degrees), indirectly reflecting the higher 
incidence of Ischemic Heart Disease in them. 
The QTc interval in diabetics (405.16±40.375) was significantly (p<0.05) 
prolonged as compared to that of non-diabetics (365.38±25.3).  
A Pourmoghaddas, et al (45) found that the prevalence of prolonged QTc interval 
was significantly higher in the case group in comparison with the control group, 8 vs. 2% 
respectively (p value = 0.012, OR = 4.3). It is comparable with our study which also 
shows long QTc in 8% of diabetics as compared to 0% in non-diabetics. 
Abnormality of parasympathetic nervous system is more common than (3 fold) 
abnormality in sympathetic nervous system. 
Mathur et al (46) found that QTc prolongation in diabetic subjects stands favourably 
as an autonomic dysfunction parameter as compared to other ANF tests. Further, QTc 
prolongation has linear positive correlation with the degree of CAN. QTc prolongation in 
diabetics with an otherwise normal heart can be used as a diagnostic test for assessment 
of cardiac autonomic neuropathy and may even be considered as a cardiac autonomic 
function test with prognostic significance.  
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Clinical significance of prolonged QTc interval 
An association between abnormally prolonged QT interval and syncope, malignant 
ventricular arrhythmias and sudden cardiac death has been found in various idiopathic 
and acquired disorders. 
Hisayoshi Oka (47) et al. in 1995, attempted to clarify the relationship of the QTc 
interval to α and β sympathetic as well as parasympathetic function tests and concluded 
that QTc prolongation is an indicator of cardiac dysautonomia. And found that the QTc 
interval in diabetics was 420 msec v/s 385 msec in nondiabetics and thus was significant. 
The ECG changes of ischemia and infarction was significantly higher in diabetics 
(36%) compared to nondiabetics (18%). 
Kannel et al (48) found that the risk of cardiovascular risk in diabetics is double that 
of nondiabetics. Various studies (49, 50) had established that prevalence of IHD is high in 
diabetics without doubt. 
The prevalence of asymptomatic silent ischemia was significantly higher in 
diabetics (27.78%) compared to non-diabetics (11.11%) in our study. 
Negrusz-Kaweck et al (51) found that the incidence of silent ischemia in type 2 
Diabetics was 20.22%.  
Other studies (52, 53) also reported a similar prevalence of asymptomatic ischemia in 
diabetics. 
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O’sullivan, et al. (54) found that silent ischemia was present in 64.7% with 
autonomic neuropathy against 41.1% without autonomic neuropathy. They concluded 
that autonomic neuropathy may prevent the development of angina pain. 
There is an increased incidence of conduction blocks in diabetics as compared to 
non-diabetics. 
Partman and Bradkey (55) found that the incidence of RBBB in diabetics is about 
2.5%.  
In this study there was an increase prevalence of both incomplete RBBB/LAFB in 
diabetics (4%/4% respectively) as compared to non-diabetics (2%/0%). 
Reduced heart ate variability is the earliest indicator of CAN (i.e., abnormalities of 
heart rate control and vascular dynamics).  
The HRBD (Heart Rate response to Deep Breathing) is abnormal in diabetics 
indicating parasympathetic damage. It was positive in 28% of diabetics in this study. 
I.Domuschiev, et al (56) found that the heart rate response to deep breathing was the 
most sensitive test, positive in 33.3% followed by heart rate response to standing (31%). 
The QTc interval correlated well with postural hypotension. All patients who had 
both symptoms and signs of postural hypotension (three) had significant QTc 
prolongation. 
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H. Oka (47) et al found that QTc interval prolongation significantly correlates with 
postural drop in SBP. In short, QTc interval may be taken as a marker of sympathetic 
nervous system dysfunction. 
Decreased sympathetic outflow to the heart and resistance vessels accompanies a 
decrease in SBP, exercise capacity and maximum heart rate. (58) 
This inability to increase rate variation may contribute to postural hypotension. (59, 
60). 
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CONCLUSIONS 
 
The following ECG manifestations were present in type 2 Diabetic patients compared to 
non-diabetic population. 
1. High resting heart rate 
2. Prolongation of PR interval 
3. Increased prevalence of ischemia and infarction 
4. Increased incidence of asymptomatic IHD 
5. Left ward QRS axis 
6. No significant difference in QRS duration. 
Following manifestations suggestive of cardiac dysautonomia in type 2 Diabetics 
were 
1. Abnormal HRBD≤10bpm 
2. Prolonged QTc interval (QTc>460 msec) in 8% 
3. Significant postural drop in SBP (>30 mm Hg) in 6% 
4. There is a positive linear correlation between QTc prolongation (QTc>460 
msec) and postural drop on SBP (>30 mm Hg) 
Thus, the evaluation of various cardiovascular reflexes in type 2 diabetics gives an easy 
and feasible bedside technique to determine the presence of cardiac dysautonomia. 
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PROFORMA 
 
 
1. Name 
2. OP/IP no. 
3. Address 
4. Age  
5. Sex 
6. Age of onset of diabetes 
7. Duration of diabetes 
8. Treatment history 
9. H/o smoking 
10. H/o alcoholism 
11. H/o anginal pain 
12. Dietary habits 
13. Body mass index 
14. Pulse 
15. Blood pressure 
1. Supine 
2.  Standing 
 
 
 
 
 
 
 
CARDIOVASCULAR SYSTEM 
ELECTROCARDIOGRAM 
1.  Rate 
2. RR interval 
3. PR interval 
4.  QRS duration 
5. QRS axis 
6. QTc interval 
7. HRBD 
a. RR interval Inspiration(Rate) 
b. RR interval Expiration(Rate) 
c. HRBD 
8. ST-T changes 
9. Conduction abnormalities 
10. Other abnormalities 
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1 Vasantha 251585 40/F - - 88 130/80 124/80 88 680 140 80 90 340 412 5 - - - 
2 Muthulingam 78157 37/M - - 92 122/78 120/78 92 650 160 60 0 320 396 9 - - - 
3 Suresh 77096 32/M - - 58 134/88 134/88 58 1030 240 60 45 380 374 15 - - - 
4 Mallika 245572 48/F + - 82 112/86 110/86 82 730 120 60 60 320 374 17 T↓II,III,aVF - - 
5 Radha 76424 43/F - - 102 100/70 98/70 102 590 160 60 60 300 390 17 - - - 
6 Manoharan 71608 47/M - - 88 110/82 110/82 88 680 140 60 45 320 388 8 T↓I,aVL,V5,6 - - 
7 Jeeva .81947 37/F - - 94 116/78 116/78 94 640 120 60 45 280 350 15 - - - 
8 Radhakrishnan 78179 45/M - - 70 124/82 124/82 70 860 200 80 75 320 345 4 T↓II,III,aVF - - 
9 Charles 76979 40/M - - 90 130/82 126/82 90 670 180 60 30 360 440 15 - - - 
10 Srinivasan 42552 50/M + - 80 122/80 122/80 80 750 140 60 30 340 392 19 T↓V1-V4 - - 
11 Annamary 19558 50/F - - 84 110/70 108/70 84 710 160 60 60 340 403 18 - icRBBB - 
12 KasthuriBai 76365 42/F - - 86 120/86 118/86 86 700 140 60 30 360 412 18 - - - 
13 Premavathy 33261 52/F + - 60 136/86 136/86 60 1000 200 60 -45 400 400 15 QV1-V4 LAFB - 
14 Pappathy 77835 42/F - - 76 110/70 108/70 76 790 180 80 45 340 382 13 - - - 
15 Radha 28989 50/F - + 56 126/80 94/76 56 1070 220 60 30 500 483 5 - - - 
16 Munusamy 15750 48/M + - 96 110/76 108/76 96 620 140 80 30 320 406 17 T↓V1-V3 - - 
17 Mahendran 40831 44/M + - 64 130/80 118/80 64 940 220 60 45 360 371 15 T↓II,III,aVF - - 
18 Ambika 76467 45/F - - 70 126/80 124/80 70 860 160 100 0 340 367 4 T↓I,aVL,V5,V6 - - 
19 Senthamarai 76408 41/F - - 86 110/80 108/80 86 700 160 90 -30 320 382 17 - - - 
20 Anbalagan 1013 55/M + - 96 116/86 116/86 96 620 120 60 45 320 406 4 T↓I,aVL - - 
21 Dhanalakhsmi 36996 35/F - - 82 116/76 108/76 82 730 140 70 0 320 374 16 - - - 
22 Yasodha 76403 45/F + - 94 112/86 110/86 94 640 160 60 -30 320 400 16 QII,III,AVF - - 
23 Krishnan 50676 43/M - - 98 126/80 122/80 98 610 140 80 45 300 384 4 - icRBBB - 
24 Kesavan 6458 46/M - - 88 110/70 108/68 88 680 160 80 30 360 437 17 - - - 
25 Parvathy 76282 42/F - - 90 120/80 118/80 90 670 160 60 30 320 391 15 - - - 
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26 Fathima.S 17828 55/F - - 96 110/76 106/72 96 620 200 60 45 320 406 6 - - - 
27 Vijaya 77860 45/F - - 92 110/80 108/80 92 650 160 60 -30 320 397 5 - - - 
28 Ravindran 17998 45/M + - 76 120/80 120/80 76 790 180 60 -45 360 405 17 QV1-V4 LAFB - 
29 Jeeva 76240 32/F - - 102 112/82 110/80 102 590 140 80 60 320 417 13 - - - 
30 Chandrasekar 78169 45/M - - 90 120/80 116/78 90 670 140 60 45 320 391 6 QI,aVF,V5,V6 - - 
31 Vasantha 76515 42/F - - 76 132/86 130/86 76 790 200 60 60 360 405 14 - - - 
32 Dilliammal 88328 56/F - - 110 120/82 120/82 110 550 140 60 45 300 405 15 - - - 
33 Jayavel 76769 39/M + - 70 110/70 108/70 70 860 160 80 0 380 410 15 T↓V1-V4 - - 
34 Mathivanan 78099 38/M - - 106 100/70 100/70 105 570 140 60 30 320 424 17 - - - 
35 Daksinamoorti 39916 35/M - - 102 120/86 118/86 102 590 160 60 0 320 417 5 - - - 
36 Rubavathy 72608 40/F - - 106 100/70 98/70 104 580 160 80 30 300 394 5 - - - 
37 Murali.K 7443 50/M - - 66 128/88 128/88 66 910 220 60 15 360 377 15 - - - 
38 Panchavarnam 12442 55/F - + 92 118/70 82/68 92 650 140 60 30 480 595 16 - - - 
39 Zeenath 245592 50/F + - 70 126/82 126/82 70 860 220 80 0 380 410 13 T↓V1-V3 - - 
40 Selvi 39710 48/F - - 78 118/86 116/86 78 770 160 60 45 320 387 15 - - - 
41 Panneerselvam 76862 37/M - - 80 136/86 134/86 80 750 120 60 45 380 439 16 - - - 
42 Krishnan 83007 41/M + - 78 120/78 120/78 78 770 140 80 30 320 365 16 T↓V1-V4 - - 
43 Poomalai 81945 52/F - + 86 126/86 94/74 86 700 160 60 0 400 478 5 T↓V1-V4 - - 
44 Sairam 78204 42/M + - 82 120/82 118/82 82 730 120 60 -30 340 398 15 QII,III,aVF - - 
45 Syed Ameed 2892 50/M - - 96 110/80 100/80 96 630 120 60 0 300 378 16 - - - 
46 Suresh 76746 29/M - - 100 110/70 106/70 100 600 140 80 45 380 491 13 - - - 
47 Thenmozhi 24667 47/F - - 90 138/82 128/78 90 670 140 80 45 300 367 15 - - - 
48 Ramachandran 50747 58/M - - 74 110/70 110/70 74 810 200 80 30 360 400 18 - - - 
49 Loorthusamy 43204 40/M + - 78 118/70 118/70 78 770 220 100 30 380 433 13 T↓II,III,aVF - - 
50 Mohan 76239 54/M - - 78 120/82 118/80 78 770 180 80 30 360 410 16 - - - 
 
 
 
 
CONTROL GROUP 
Blood pressure Electrocardiogram 
S
I
.
N
O
.
 
NAME 
 
 
IP/OP 
NO. 
A
G
E
/
S
E
X
 
H
/
o
 
a
n
g
i
n
a
l
 
p
a
i
n
 
H
/
o
 
p
o
s
t
u
r
a
l
 
g
i
d
d
i
n
e
s
s
 
P
u
l
s
e
 
 
(
b
p
m
)
 
  
R
a
t
e
 
(
b
p
m
)
 
R
-
R
(
m
s
e
c
)
 
P
-
R
 
(
m
s
e
c
)
 
Q
R
S
 
 
D
u
r
a
t
.
(
m
s
e
c
)
 
Q
R
S
 
a
x
i
s
 
(
d
e
g
r
e
e
s
)
 
Q
T
 
I
n
t
e
r
v
a
l
 
(
m
s
e
c
)
 
Q
T
c
 
I
n
t
e
r
v
a
l
 
(
m
s
e
c
)
 
S
T
 
–
T
 
C
h
a
n
g
e
s
 
C
o
n
d
u
c
t
i
o
n
 
a
b
n
o
r
m
a
l
i
t
i
e
s
 
O
t
h
e
r
 
a
b
n
o
r
m
a
l
i
t
i
e
s
 
1 Amutha 10357 45/F - - 82 130/80 128/80 82 730 160 80 30 300 352 - - - 
2 Adhilakhsmi 37736 43/F - - 92 138/80 136/80 92 650 160 60 60 300 372 - - - 
3 Malarkodi 29156 47/F - - 80 130/82 126/82 82 730 130 60 0 320 375 - - - 
4 Palaniammal 11172 36/F - - 90 126/80 124/80 90 670 140 60 60 340 415 - - - 
5 Annapoorani 25775 47/F + - 76 110/80 108/80 76 790 160 80 -15 360 405 Q II,III,aVF - - 
6 Shanthi 14422 41/F - - 66 126/80 120/78 66 910 140 60 45 360 377 - - - 
7 Arul 45866 36/M - - 84 116/86 116/86 83 790 140 60 30 300 338 - icRBBB - 
8 Krishnan 34325 36/M - - 78 120/82 120/82 78 770 140 80 100 340 387 - - - 
9 Lilli 36777 48/F - - 92 128/82 126/80 92 650 150 60 70 260 322 - - - 
10 Lingammal 29993 43/F - - 62 110/80 110/80 62 960 120 60 45 340 347 - - - 
11 Jayalakhsmi 32674 40/F - - 68 112/82 110/80 68 880 140 60 60 360 384 - - - 
12 Bakiya 6983 55/F - - 72 120/80 120/80 72 830 120 80 45 340 373 - - - 
13 Subramani 51588 51/M + - 82 132/86 130/86 82 730 120 60 30 300 351 T↓V1-V4 - - 
14 Srinivasan 38234 38/M - - 78 120/82 120/82 78 770 140 60 60 300 342 - - - 
15 Varadhan 4801 35/M - - 78 110/70 108/70 78 770 140 60 60 320 365 - - - 
16 Shanthi 14421 41/F - - 90 100/70 100/70 90 670 120 60 60 340 415 - - - 
17 Moorthy 52282 40/M - - 70 120/86 118/86 70 860 180 70 70 340 366 - - - 
18 Pushpalatha 25102 45/F - - 60 136/86 136/86 60 1000 120 60 60 360 360 - - - 
19 Sumathy 15912 50/F - - 70 110/70 108/70 70 860 120 60 50 380 410 - - - 
20 Kasthuri 32763 48/F - - 86 120/80 114/80 86 700 120 80 60 300 359 - - - 
21 Prabhu 44137 28/M - - 80 110/76 108/76 80 790 160 60 90 300 338 - - - 
22 Jothi 7808 45/F - - 62 110/80 108/78 62 970 160 60 30 360 366 - - - 
23 Thirunavukarasu 600 55/M + - 80 120/80 120/80 79 760 140 80 -15 320 367 Q II,III,aVF - - 
24 Veeraiah 19805 40/M - - 78 112/82 110/82 78 770 120 60 0 300 342 - - - 
25 Raju 26624 32/M - - 70 120/80 116/78 70 860 140 60 45 360 388 - - - 
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26 Venkatesan 11636 46/M + - 74 106/82 104/82 74 810 150 60 45 360 400 QV1-V4 - - 
27 Muthammal 14429 40/F - - 68 110/86 110/86 68 880 140 60 45 380 405 - - - 
28 Guru 40829 45/M - - 78 100/70 98/70 78 770 120 60 60 320 365 - - - 
29 Pattammal 17064 55/F - - 68 110/82 110/82 68 880 160 80 60 360 384 - - - 
30 Rajan 38989 48/M - - 74 116/78 116/78 74 810 130 60 90 320 356 - - - 
31 Kalavathy 13633 52/F - - 72 124/82 124/82 68 880 140 60 30 360 364 - - - 
32 Anjaladevi 31687 50/F - - 56 130/82 126/82 56 1070 160 60 60 400 387 - - - 
33 Annamalai 44144 45/M - - 58 120/86 118/86 58 1030 120 80 30 340 335 T↓V1-V4 - - 
34 Kattan 15110 40/M - - 86 136/86 136/86 86 700 140 60 0 300 359 - - - 
35 Dhas 20723 45/M - - 88 126/80 120/78 87 680 130 60 90 300 364 - - - 
36 Venkatesh 22227 50/M - - 86 116/86 116/86 86 700 120 80 40 280 335 - - - 
37 Venkatesan 1305 50/M - - 70 120/82 120/82 70 860 120 60 30 340 367 - - - 
38 Mala 406101 41/F - - 60 128/82 126/80 61 980 120 80 45 340 344 - - - 
39 Mallika 12708 34/F - - 76 112/86 110/86 76 790 130 60 0 360 405 - - - 
40 Parthiban 18112 46/M + - 58 126/80 124/80 58 1030 150 60 30 340 335 T↓V1-V4 - - 
41 Kuppan 10766 59/M - - 100 100/70 100/70 100 600 120 80 0 280 361 - - - 
42 Anand 50665 41/M - - 70 120/80 118/80 70 860 120 60 90 320 345 - - - 
43 Yamuna 29749 52/F + - 72 126/80 124/80 72 830 120 60 70 320 351 T↓II,III,aVF - - 
44 Gopinath 24724 41/M - - 66 110/80 108/80 66 910 140 80 45 320 335 - - - 
45 Palanisamy 6808 48/M + - 98 116/86 116/86 98 610 120 60 90 300 384 T↓V1-V4 - - 
46 Loganayagi 10389 35/F - - 82 110/76 108/76 82 730 160 60 75 320 375 - - - 
47 Kamurunnisha 31764 57/F -  68 110/80 108/78 68 880 140 60 60 340 362 - - - 
48 Ravi 12634 43/M - - 70 110/82 110/82 70 860 180 6`0 60 280 302 - - - 
49 Mani 16901 43/M - - 80 130/82 126/82 80 750 140 60 60 340 393 - - - 
50 Muthulaksmi 36721 42/F + - 60 126/80 124/80 60 1000 160 60 45 340 340 T↓II,III,aVF - - 
